Patient Characteristics (n = 261)
| Characteristic | Data |
| Age at time of scan (y) | 72 (49–88) |
| Further treatment | |
| External radiation after RP | 105 (40) |
| Antihormonal treatment | 97 (3) |
| ADT in 6 mo preceding scan | 67 (26) |
| Gleason score | |
| ≤6 | 12 (4.6) |
| 7 | 110 (42) |
| ≥8 | 87 (33) |
| Unknown | 52 (20) |
| Pathologic primary tumor staging at RP | |
| pT2 | 76 (29) |
| pT3 | 138 (53) |
| pT4 | 6 (2.3) |
| Unknown | 41 (15) |
| Pathologic regional lymph node staging at RP | |
| pN0 | 146 (56) |
| pN1 | 66 (25) |
| pNx | 49 (19) |
| Positive margin at RP | |
| R0 | 94 (36) |
| R1 | 73 (28) |
| Unknown | 94 (36) |
| Initial PSA value (ng/mL) | 10.5 (0.09–290) |
| Time between surgery and PET (mo) | 56 (0–336) |
| Last PSA value before PET (ng/mL)* | 0.961 (0.01–400.0) |
| Injected activity (MBq) | 336 (191–417) |
| Uptake time (min) | 76 (50–220) |
↵* PSA value obtained within 4 wk before 18F-rhPSMA-7 PET examination.
RP = radical prostatectomy.
Qualitative data are expressed as numbers followed by percentages in parentheses; continuous data are expressed as median followed by range in parentheses.